Soleus Capital Management, L.P.

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1802630 GREENWICH, CT

Position in MIRM

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$36,980,268

-$8,329,501 QoQ

Shares Held

400,306

-30.2% QoQ

Ownership

0.656%

of shares outstanding

% of Portfolio

1.47%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Soleus Capital Management, L.P. holds $1,422,770,178 across 59 Biotechnology names. MIRM ranks #11 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	1,153,087	$297,865,433
2	CELC	Celcuity Inc.	1,284,378	$146,598,904
3	TGTX	Tg Therapeutics, Inc.	4,029,319	$133,853,977
4	PRAX	Praxis Precision Medicines, Inc.	330,517	$106,489,272
5	VCEL	Vericel Corp	2,549,079	$82,003,871
6	GERN	Geron Corp	41,508,659	$61,847,901
7	IMUX	Immunic, Inc.	4,500,000	$49,950,000
8	EWTX	Edgewise Therapeutics, Inc.	1,449,915	$45,672,322

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$36,980,268	400,306	-30.2%	Shares	Sole	2026-05-14
2025-12-31	$45,309,769	573,614	+285.8%	Shares	Sole	2026-02-12
2025-09-30	$10,900,903	148,696	-50.2%	Shares	Sole	2025-11-14
2025-06-30	$15,200,639	298,696	+190.0%	Shares	Sole	2025-08-15
2023-09-30	$3,254,800	103,000	-41.5%	Shares	Sole	2023-11-14
2023-06-30	$4,553,120	176,000	-27.3%	Shares	Sole	2023-08-14
2023-03-31	$5,812,840	242,000	+78.4%	Shares	Sole	2023-05-15
2022-09-30	$2,849,334	135,618	-30.8%	Shares	Sole	2022-11-14
2022-06-30	$3,814,510	196,018	-42.9%	Shares	Sole	2022-08-15
2022-03-31	$7,563,870	343,500	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.